{"id":"W4379093489","doi":"10.57264/cer-2023-0016","title":"Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis","year":2023,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Ofatumumab; Alemtuzumab; Ocrelizumab; Natalizumab; Internal medicine; Placebo; Multiple sclerosis; Lipoarabinomannan; Oncology; Rituximab; Disease; Tuberculosis; Immunology; Alternative medicine; Pathology; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0166618,0.002454183,0.01602615,0.005793582,0.0004616866,0.002277152,0.001897904,0.001903847,0.004280893],"category_scores_gemma":[0.03489439,0.001181635,0.02726225,0.005879811,0.0006146588,0.001473275,0.00138417,0.001879683,0.0002763794],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00227847,"about_ca_system_score_gemma":0.002515814,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005583438,"about_ca_topic_score_gemma":0.01060994,"domain_scores_codex":[0.9878293,0.007814044,0.002052055,0.001059182,0.0009842134,0.0002612007],"domain_scores_gemma":[0.973905,0.02143451,0.002770181,0.0005465464,0.001097552,0.0002460742],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002480616,0.00002663493,0.003216628,0.2300663,0.7500011,0.00006017984,0.00004580573,0.0006231873,0.0001375328,0.0001925224,0.000495692,0.01265385],"study_design_scores_gemma":[0.0008960454,0.0001778813,0.00257951,0.01485149,0.9796847,0.00005743241,0.00002608955,0.0002892427,0.00006661495,0.000260125,0.001096948,0.00001393642],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004759955,0.9932746,0.0006566161,0.000227568,0.0001245817,0.000198063,0.0004946248,0.00002062003,0.0002434171],"genre_scores_gemma":[0.2430988,0.7501729,0.003276119,0.0007211827,0.0003081683,0.001007464,0.001109629,0.00003292591,0.0002727357],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0166618,"threshold_uncertainty_score":0.08811706,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.7093580791148476,"score_gpt":0.5626411172863962,"score_spread":0.1467169618284514,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}